These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19350461)

  • 21. [Effector T cells].
    Leipe J; Chang HD
    Z Rheumatol; 2015 Feb; 74(1):14-9. PubMed ID: 25608674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-17 and Th17 cells in human inflammatory diseases.
    Miossec P
    Microbes Infect; 2009 Apr; 11(5):625-30. PubMed ID: 19371791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-17 and type 17 helper T cells.
    Miossec P; Korn T; Kuchroo VK
    N Engl J Med; 2009 Aug; 361(9):888-98. PubMed ID: 19710487
    [No Abstract]   [Full Text] [Related]  

  • 24. IL-37 Alleviates Rheumatoid Arthritis by Suppressing IL-17 and IL-17-Triggering Cytokine Production and Limiting Th17 Cell Proliferation.
    Ye L; Jiang B; Deng J; Du J; Xiong W; Guan Y; Wen Z; Huang K; Huang Z
    J Immunol; 2015 Jun; 194(11):5110-9. PubMed ID: 25917106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gammadelta T cell receptors without a job.
    Kapsenberg ML
    Immunity; 2009 Aug; 31(2):181-3. PubMed ID: 19699169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-IL-17 mAbs herald new options in psoriasis.
    Garber K
    Nat Biotechnol; 2012 Jun; 30(6):475-7. PubMed ID: 22678368
    [No Abstract]   [Full Text] [Related]  

  • 27. Embracing novel cytokines in RA - complexity grows as does opportunity!
    Hueber AJ; Asquith DL; McInnes IB; Miller AM
    Best Pract Res Clin Rheumatol; 2010 Aug; 24(4):479-87. PubMed ID: 20732646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis.
    Hueber W; Patel DD; Dryja T; Wright AM; Koroleva I; Bruin G; Antoni C; Draelos Z; Gold MH; ; Durez P; Tak PP; Gomez-Reino JJ; ; Foster CS; Kim RY; Samson CM; Falk NS; Chu DS; Callanan D; Nguyen QD; ; Rose K; Haider A; Di Padova F
    Sci Transl Med; 2010 Oct; 2(52):52ra72. PubMed ID: 20926833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokine targeting in psoriasis and psoriatic arthritis: beyond TNFalpha.
    MclInnes IB
    Ernst Schering Res Found Workshop; 2006; (56):29-44. PubMed ID: 16329645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From physiology to disease and targeted therapy: interleukin-6 in inflammation and inflammation-associated carcinogenesis.
    Rath T; Billmeier U; Waldner MJ; Atreya R; Neurath MF
    Arch Toxicol; 2015 Apr; 89(4):541-54. PubMed ID: 25632846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of Th17 cells in rheumatoid arthritis].
    Himer L; Balog A; Szebeni B; Szakál DN; Sziksz E; Reusz G; Tulassay T; Vannay A
    Orv Hetil; 2010 Jun; 151(25):1003-10. PubMed ID: 20519185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.
    Williams RO; Paleolog E; Feldmann M
    Curr Opin Pharmacol; 2007 Aug; 7(4):412-7. PubMed ID: 17627887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Th17 T cells: linking innate and adaptive immunity.
    Stockinger B; Veldhoen M; Martin B
    Semin Immunol; 2007 Dec; 19(6):353-61. PubMed ID: 18023589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ixekizumab (Taltz)--a second IL-17A inhibitor for psoriasis.
    Med Lett Drugs Ther; 2016 May; 58(1494):59-60. PubMed ID: 27148922
    [No Abstract]   [Full Text] [Related]  

  • 35. The link between IL-23 and Th17 cell-mediated immune pathologies.
    McGeachy MJ; Cua DJ
    Semin Immunol; 2007 Dec; 19(6):372-6. PubMed ID: 18319054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRPM channels as potential therapeutic targets against pro-inflammatory diseases.
    Zierler S; Hampe S; Nadolni W
    Cell Calcium; 2017 Nov; 67():105-115. PubMed ID: 28549569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modern Drug Discovery and Development--GTCbio's Third Annual Summit. Drug-Delivery Technology. 28-30 November 2007, San Francisco, CA, USA.
    Lee RJ
    IDrugs; 2008 Feb; 11(2):101-4. PubMed ID: 18240093
    [No Abstract]   [Full Text] [Related]  

  • 38. IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer.
    Neurath MF; Finotto S
    Cytokine Growth Factor Rev; 2011 Apr; 22(2):83-9. PubMed ID: 21377916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging therapeutic strategies for chronic inflammatory diseases.
    Ferrer E
    Drug News Perspect; 2006; 19(6):353-8. PubMed ID: 16971972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Innate Th2-type immune responses and the natural helper cell, a newly identified lymphocyte population.
    Koyasu S; Moro K
    Curr Opin Allergy Clin Immunol; 2011 Apr; 11(2):109-14. PubMed ID: 21301328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.